Combination comprising a cannabinoid receptor binding compound and an opioid

Details for Australian Patent Application No. 2009218456 (hide)

Owner Novartis AG

Inventors Evans, Thomas George; Johns, Donald

Agent Davies Collison Cave

Pub. Number AU-A-2009218456

PCT Pub. Number WO2009/106574

Priority 08152104.9 28.02.08 EP

Filing date 26 February 2009

Wipo publication date 3 September 2009

International Classifications

A61K 31/015 (2006.01)

A61K 31/121 (2006.01) - acyclic

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

A61K 31/4468 (2006.01) - having a nitrogen atom directly attached in position 4, e.g. clebopride, fentanyl

A61K 31/485 (2006.01) - Morphinan derivatives, e.g. morphine, codeine

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

Event Publications

2 September 2010 PCT application entered the National Phase

  PCT publication WO2009/106574 Priority application(s): WO2009/106574

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009218457-Lipases with high specificity towards short chain fatty acids and uses thereof

2009218436-Compositions and methods for augmentation and regeneration of living tissue in a subject